AJR Am J Roentgenol
- DEIPOLYI AR, Ward RC, Riaz A, Vogl TJ, et al
Locoregional Therapies for Primary and Metastatic Breast Cancer: AJR Expert Panel
Narrative Review.
AJR Am J Roentgenol. 2023 Jun 28. doi: 10.2214/AJR.23.29454.
Am J Gastroenterol
- HIRODE G, Hansen BE, Chen CH, Su TH, et al
Erratum: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog
Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients
With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol. 2024 Mar 8. doi: 10.14309/ajg.0000000000002718.
Biochem Biophys Res Commun
- HUANG W, Qian Y, Lin J, Wang F, et al
Baicalein alleviates intrahepatic cholestasis by regulating bile acid metabolism
via an FXR-dependent manner.
Biochem Biophys Res Commun. 2024;705:149670.
BMC Cancer
- LIANG Y, Zhong D, Zhang Z, Su Y, et al
Impact of preoperative antiviral therapy on the prognosis of hepatitis B
virus-related hepatocellular carcinoma.
BMC Cancer. 2024;24:291.
- HUANG JX, Zhang X, Tang M, Zhang Q, et al
Comprehensive evaluation of serum hepatic proteins in predicting prognosis among
cancer patients with cachexia: an observational cohort study.
BMC Cancer. 2024;24:293.
- WONGLHOW J, Sunpaweravong P, Sathitruangsak C, Dechaphunkul A, et al
LABS score- a prognostic tool for FOLFOX4-treated advanced hepatocellular
carcinoma and real-world efficacy: a single-center retrospective study.
BMC Cancer. 2024;24:281.
- LIN J, Li J, Kong Y, Yang J, et al
Construction of a prognostic model for hepatocellular carcinoma patients
receiving transarterial chemoembolization treatment based on the Tumor Burden
Score.
BMC Cancer. 2024;24:306.
BMC Gastroenterol
- KILONZO SB, Kamala E, Jaka H, Ngoya P, et al
Non-alcoholic fatty liver disease in Tanzania: prevalence, determinants, and
diagnostic performance of triglycerides-glucose index and triglycerides-glucose
index -body mass index compared to the hepatic ultrasound in overweight and obese
individuals.
BMC Gastroenterol. 2024;24:96.
- LIU B, Dou J, Cao J
Nuclear respiratory factor 1 regulates super enhancer-controlled SPIDR to protect
hepatocellular carcinoma cells from oxidative stress.
BMC Gastroenterol. 2024;24:97.
- LIU C, Li Z, Zhang Z, Li J, et al
Prediction of survival and analysis of prognostic factors for patients with AFP
negative hepatocellular carcinoma: a population-based study.
BMC Gastroenterol. 2024;24:93.
- FANG G, Liu S, Liu B
Preventive and therapeutic effects of rifaximin on hepatic encephalopathy with
differential application dosages and strategies: a network meta-analysis.
BMC Gastroenterol. 2024;24:94.
Br J Surg
- PENG W, Wu Y, Zhang X, Li C, et al
Liver transplantation for advanced hepatocellular carcinoma after downstaging
with consequential lenvatinib, transcatheter arterial chemoembolization and
camrelizumab.
Br J Surg. 2024;111:znae048.
- FAN ZQ, Serenari M, Lv X, Schwartz M, et al
Prognostic significance of nodular number in patients undergoing hepatectomy of
intermediate-stage hepatocellular carcinoma.
Br J Surg. 2024;111:znae047.
Dig Dis Sci
- PETROSYAN R, Endres P, Ufere NN, St Hillien SA, et al
Healthcare Resource Utilization and Goals of Care Discussions in Patients with
Cirrhosis and Acute Kidney Injury.
Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08317.
- PATEL AA, Walling A, Bansal A
A New Look at Goals-of-Care Discussions in Patients with Cirrhosis and Acute
Kidney Injury.
Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08300.
- REN J, Yao X, Yang M, Cheng S, et al
Kinesin Family Member-18A (KIF18A) Promotes Cell Proliferation and Metastasis in
Hepatocellular Carcinoma.
Dig Dis Sci. 2024 Mar 6. doi: 10.1007/s10620-024-08321.
Endoscopy
- SORGE A, Pessarelli T, Elli L, Nandi N, et al
Band-on-band endoscopic variceal ligation: a technique for the treatment of
esophageal varices in case of band misplacement.
Endoscopy. 2024;56.
- BINDA C, Dajti E, Giuffrida P, Trebbi M, et al
Efficacy and safety of endoscopic ultrasound-guided hepatico-gastrostomy: a
meta-regression analysis.
Endoscopy. 2024 Mar 6. doi: 10.1055/a-2282-3350.
Eur J Pediatr
- DE CUEVILLAS B, Lubrecht J, Navas-Carretero S, Vreugdenhil A, et al
Sleep duration is associated with liver steatosis in children depending on body
adiposity.
Eur J Pediatr. 2024;183:779-789.
Gastroenterology
- WONG RJ, Yang Z, Cheung R, Singal AK, et al
Impact of Longitudinal Alcohol Use Patterns on Long-Term Risk of Cirrhosis Among
U.S. Veterans with Steatotic Liver Disease.
Gastroenterology. 2024 Feb 28:S0016-5085(24)00238.
Gastrointest Endosc
- WANG TJ, Jirapinyo P, Shah R, Schuster K, et al
Endoscopic Ultrasound Guided Liver Palpation As a Screening Tool for Advanced
Fibrosis and Cirrhosis in Patients with Suspected Metabolic
Dysfunction-Associated Steatotic Liver Disease: A Pilot Study.
Gastrointest Endosc. 2024 Feb 29:S0016-5107(24)00137.
Hepatology
- GUO Q, Wang J, Wang G, Wang X, et al
Letter to the Editor: Is right heart assessment vital for evaluating
Terlipressin-related outcomes in Hepatorenal Syndrome-AKI?
Hepatology. 2024 Mar 8. doi: 10.1097/HEP.0000000000000832.
- BERENGUER J, Aldamiz-Echevarria T, Hontanon V, Fanciulli C, et al
Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV
coinfected patients with advanced Fibrosis/Cirrhosis.
Hepatology. 2024 Mar 7. doi: 10.1097/HEP.0000000000000838.
- SEMMLER G, Hartl L, Mendoza YP, Simbrunner B, et al
Simple blood tests to diagnose compensated advanced chronic liver disease and
stratify risk of clinically significant portal hypertension.
Hepatology. 2024 Mar 6. doi: 10.1097/HEP.0000000000000829.
- AMPUERO J, Lucena A, Berenguer M, Hernandez-Guerra M, et al
Predictive factors for decompensating events in cirrhotic patients with primary
biliary cholangitis under different lines of therapy.
Hepatology. 2024 Mar 6. doi: 10.1097/HEP.0000000000000826.
- ROY A, Kajal K, Izzy M, Sihag BK, et al
Reply: Is right heart assessment vital for evaluating terlipressin-related
outcomes in Hepatorenal Syndrome-AKI ?
Hepatology. 2024 Mar 5. doi: 10.1097/HEP.0000000000000833.
- KUMAR M, Venishetty S, Jindal A, Bihari C, et al
Tranexamic acid in upper gastrointestinal bleed in patients with cirrhosis - a
randomized controlled trial.
Hepatology. 2024 Mar 5. doi: 10.1097/HEP.0000000000000817.
J Gastroenterol Hepatol
- BALE G, Kulkarni AV, Padaki NR, Menon PB, et al
Comparing rare variants versus common in the pathogenesis of nonalcoholic fatty
liver disease: a whole exome sequencing approach.
J Gastroenterol Hepatol. 2024;39:587-595.
J Hepatol
- ROCA-FERNANDEZ A, Banerjee R, Thomaides-Brears H, Telford A, et al
Liver disease is a significant risk factor for cardiovascular outcomes - A UK
Biobank study.
J Hepatol. 2023;79:1085-1095.
- LEI Z, Yu J, Wu Y, Shen J, et al
CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis.
J Hepatol. 2024;80:194-208.
- ZHANG Q, Wei T, Jin W, Yan L, et al
Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular
carcinoma by reprogramming glutamine metabolism.
J Hepatol. 2024;80:293-308.
PLoS One
- DUHRING S, Schuster S
Studying mixed-species biofilms of Candida albicans and Staphylococcus aureus
using evolutionary game theory.
PLoS One. 2024;19:e0297307.
- CHEN Q, Sun Q, Zhang J, Li B, et al
Cost-effectiveness analysis of Tislelizumab vs Sorafenib as the first-line
treatment of unresectable hepatocellular carcinoma.
PLoS One. 2024;19:e0295090.
- STAUFFER WT, Goodman AZ, Bobardt M, Ure DR, et al
Mice lacking cyclophilin B, but not cyclophilin A, are protected from the
development of NASH in a diet and chemical-induced model.
PLoS One. 2024;19:e0298211.
- YANG Y, Mirzaei G
Performance analysis of data resampling on class imbalance and classification
techniques on multi-omics data for cancer classification.
PLoS One. 2024;19:e0293607.
- LI YS, Xia YG, Liu YL, Jiang WR, et al
Metabolic-dysfunction associated steatotic liver disease-related diseases,
cognition and dementia: A two-sample mendelian randomization study.
PLoS One. 2024;19:e0297883.
- MCTEER M, Applegate D, Mesenbrink P, Ratziu V, et al
Machine learning approaches to enhance diagnosis and staging of patients with
MASLD using routinely available clinical information.
PLoS One. 2024;19:e0299487.
- NAH EH, Choi YJ, Cho S, Park H, et al
Changes in nonalcoholic fatty liver disease and M2BPGi due to lifestyle
intervention in primary healthcare.
PLoS One. 2024;19:e0298151.
- BUDZYNSKA A, Kubik A, Kacperski K, Pastusiak P, et al
PET/CT and SPECT/CT imaging of 90Y hepatic radioembolization at therapeutic and
diagnostic activity levels: Anthropomorphic phantom study.
PLoS One. 2024;19:e0271711.
Transplant Proc
- IMAOKA K, Ohira M, Hattori M, Chogahara I, et al
Immunotherapy Using Activated Natural Killer Cells Improves Postoperative
Neutrophil-to-Lymphocyte Ratio and Long-Term Prognosis of Living Donor Liver
Transplant Recipients With Hepatocellular Carcinoma.
Transplant Proc. 2024 Mar 4:S0041-1345(24)00129.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016